Sign in
Explore the registryTrack Selumetinib's trials

KOMET

Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas

SelumetinibOngoingActive not recruitingPhase 3Open NCT04924608 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

KOMET · Trial Tracker · ComplyRx